BioAgilytix

Join the excitement in Barcelona, Spain, from 20 – 22 November for the 17th EBF Open Symposium, where we will exchange innovative ideas and leading practices in bioanalysis. Visit us at booth 3C to discover our full range of pharmacokinetic (PK), immunogenicity, biomarker, and CMC bioanalytical testing services, and speak to our highly qualified scientific leaders onsite. Connect with us at our three podium presentations and two poster sessions given by our expert team of scientists from Hamburg. Take the initiative and set up a meeting with us onsite. https://bit.ly/3AydM8l #EBF2024 #lifesciences #Healthcare #futuremedicine #innovationinscience #PrecisionMedicine #Bioanalysis

We're thrilled to announce that we will be exhibiting at #ACTOX2024 in Austin, Texas. Be sure to attend Michelle Miller, PhD's presentation “Strategies for Long-Term Success: Streamlining the Preclinical to Clinical Assay Transition,” on November 19 at 8:00am in room 202. At BioAgilytix, we understand that each toxicology program presents unique challenges. We tailor our bioanalytical solutions to provide the most appropriate assay services to deliver timely, efficient, and accurate results for our clients. Our laboratories support both non-GLP and GLP-compliant studies in a fit for purpose manner to meet your regulatory needs. We routinely provide SEND-compliant data to support regulatory filings. Schedule a meeting in advance and discover how we can work together to achieve your goals. We can’t wait to connect with you in Austin! #Toxicology #DrugDevelopment #BioAgilytix #ACTMeeting2024 #ACTOX2024 #Pharmacokinetics #Immunogenicity #Biomarkers https://bit.ly/3YzicUC

We are pleased to announce that we are onsite at the 15th Annual World ADC Event Series Meeting in San Diego at the Town and Country Resort, and we can't wait to connect with you at booth 518! Our team is eager to discuss how we can collaborate to advance your programs by leveraging our expertise in ADC development. Whether you're interested in innovative strategies, overcoming complex challenges, or exploring new avenues in ADCs, we're here to partner with you every step of the way. #WorldADC #ADC #PharmaInnovation #Biotech #DrugDevelopment #BioAgilytix #AntibodyDrugConjugates #InnovationInBiotech

November 6th is just around the corner! Join us at BioM Biotech Cluster Development GmbH to explore bioanalytical strategies that advance drug development. Schedule a meeting today.

BioAgilytix is excited to be attending the HireLifeScience.com Career Fair in Boston next Thursday, November 7th in Boston! This event is a perfect opportunity for life science professionals seeking their next career step. Have you registered? Be sure to stop by the #BioAgilytix booth to connect with Jen Russum and other members of our Boston team. We can’t wait to meet you and discuss exciting career opportunities at BioAgilytix! 👉 Don’t forget to check out the BioAgilytix Careers Page for current openings in our Boston lab! https://bit.ly/481Mgee

Join us at World ADC Event Series 15th Annual Meeting in San Diego at booth 518 on November 5-6th! We're excited to explore how our expertise in ADC advancements can support your drug development program. Whether you're in the early stages of development or advancing to clinical trials, we're here to provide tailored solutions that align with your specific needs. Our experience in creating antibody drug conjugates (ADCs) ensures high specificity and therapeutic efficacy, offering a transformative approach to targeting tumor cells while preserving healthy tissue. Let's discuss how we can partner with you to turn challenges into opportunities and drive success in the pharmaceutical and biotech industries. https://bit.ly/4dTJZVa #WorldADC #ADC #PharmaInnovation #Biotech #DrugDevelopment #BioAgilytix #AntibodyDrugConjugates #InnovationInBiotech

Our team enjoyed being onsite at European Society of Gene and Cell Therapy in Rome, Italy last week for the annual cell and gene therapy event. Scientific Officer Robert Nelson, PhD shared two posters. The first was about screening assays for Anti-AAV antibodies in support of gene therapies (TAb or NAb) and the second featured flow cytometry as a tool for potency determination in ATMP development. We were happy to meet face-to-face with so many attendees at our booth and posters, and to discuss how our bioanalytical and CMC capabilities can support cell and gene therapy programs through preclinical and clinical development phases. Did you miss us at ESGCT? Be sure to reach out to our scientific team today: https://bit.ly/44luZLt #ESGCT2024 #LaNuvola #genetherapy #celltherapy #cellandgenetherapy #CMC #potencyassays #immunogenicity #PCR #flowcytometry

Attending World ADC in San Diego? We're excited to share that our Scientific Officer, Jessica Bridges Weaver, will be showcasing a poster on Tuesday, November 5th, from 6:30-7:30 PM. Her presentation is titled "Development of Critical Quality Attributes as Part of Antibody Drug Conjugate Control Strategy" and promises to be quite insightful. Jessica will delve into the intricacies of analytical control strategies vital for monitoring critical quality attributes (CQAs) in the development of biotherapeutics. The session will highlight the complexity of ADCs, which merge a complex protein with a chemically bonded cargo to precisely control drug activity. Understanding these CQAs is crucial to ensuring a robust process and delivering consistently safe and effective drugs. Don't miss this opportunity to gain insights into methodologies for monitoring impactful CQAs common across ADCs. Our team will be available throughout the event at Booth 518 to discuss our ADC expertise and explore how we can support your needs. https://bit.ly/4dTJZVa #WorldADC #ADC #PharmaInnovation #Biotech #DrugDevelopment #BioAgilytix #AntibodyDrugConjugates #InnovationInBiotech #CMC

As we approach the 15th Annual @World ADC meeting in San Diego, we are excited to explore potential partnerships and collaborations in the cutting-edge field of Antibody Drug Conjugates (ADCs) for oncology. ADCs are transforming cancer treatment by precisely targeting cancer cells, administering potent therapies directly where they are needed, while protecting healthy tissue in the process. We are particularly looking forward to Scientific Officer Lynn Kamen’s presentation titled, "Bioanalytical Strategies for Antibody Drug Conjugate Development," scheduled for November 5th from 6:30-7:30 PM. In her talk, Dr. Kamen will delve into vital bioanalytical strategies for assessing ADC pharmacokinetics and immunogenicity, emphasizing the significance of both molecular components for ensuring efficacy and safety. Join us in connecting with researchers and industry leaders as we work towards advancing oncology treatments. We can't wait to see you at booth 518 in San Diego! https://bit.ly/4dTJZVa #WorldADC #ADC #PharmaInnovation #Biotech #DrugDevelopment #BioAgilytix #AntibodyDrugConjugates #InnovationInBiotech

Our team is onsite at European Society of Gene and Cell Therapy in Rome, Italy. Visit booth E14 to learn from our experts how our bioanalytical capabilities can support your next gene and cell therapy project. Be sure to have a chat with Scientific Officer Robert Nelson, PhD at two poster presentations - “Screening assays for Anti-AAV antibodies in support of gene therapies (TAb or NAb?)” during poster session II and "Flow cytometry as a tool for potency determination in ATMP development” during poster session IV. Learn more about our cell and gene therapy services here: https://bit.ly/3zVY1rK #ESGCT2024 #LaNuvola #genetherapy #celltherapy #cellandgenetherapy #CMC #potencyassays #immunogenicity #PCR #flowcytometry